Monalizumab: inhibiting the novel immune checkpoint NKG2A

by Thorbald van Hall, Pascale André, Amir Horowitz, Dan Fu Ruan, Linda Borst, Robert Zerbib, Emilie Narni-Mancinelli, Sjoerd H. van der Burg, Eric Vivier
Published 2019-10-01

483 Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis

by Mikael Ebbo, Nicolas Schleinitz, Yannis Morel, Luciana Batista, Sabrina Carpentier, Romain Remark, Eric Vivier, Frédéric Vély, Olivier Demaria, Julien Carvelli, Nassima Chouaki Benmansour, Joanna Fares, Marie-Laure Thibult, Ariane Morel, Agnes Represa, Robert Zerbib
Published 2020-11-01

Thalidomide versus dexamethasone for the treatment of relapsed and/or refractory multiple myeloma: results from OPTIMUM, a randomized trial

by Martin Kropff, Honorata Giongco Baylon, Jens Hillengass, Tadeusz Robak, Roman Hajek, Peter Liebisch, Stefan Goranov, Cyrille Hulin, Joan Bladé, Tommaso Caravita, Herve Avet-Loiseau, Thomas M. Moehler, Claire Pattou, Lela Lucy, Elisabeth Kueenburg, Axel Glasmacher, Robert Zerbib, Thierry Facon
Published 2012-05-01